EuroEyes International Eye Clinic Limited
HKSE: 1846.HK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Hong Kong Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Jörn Slot Jörgensen
- Employees
- 322
- Headquarters
- Hamburg, Germany
- IPO year
- 2019
- Market cap
- HK$923.4M
- Website
- https://www.euroeyes.hk
Loading 1846…
Loading profile data…Frequently asked questions about 1846
What does EuroEyes International Eye Clinic Limited (1846.HK) do?
EuroEyes International Eye Clinic Limited provides vision correction services in Germany, Denmark, and the People's Republic of China. The company offers refractive laser surgery, which include ReLEx SMILE and FemtoLASIK; phakic lens (ICL) surgery; lens exchange surgery comprising the monofocal and trifocal lens exchange surgery; and PRK/LASEK a...
Where does 1846.HK trade?
EuroEyes International Eye Clinic Limited (1846.HK) trades on the Hong Kong Stock Exchange.
What sector is 1846.HK in?
EuroEyes International Eye Clinic Limited (1846.HK) operates in the Healthcare sector, specifically in the Medical - Care Facilities industry.
Who is the CEO of EuroEyes International Eye Clinic Limited?
Jörn Slot Jörgensen is the chief executive officer of EuroEyes International Eye Clinic Limited (1846.HK).
Where is EuroEyes International Eye Clinic Limited headquartered?
EuroEyes International Eye Clinic Limited is headquartered in Germany.
Does 1846.HK pay a dividend?
Yes — EuroEyes International Eye Clinic Limited (1846.HK) paid a trailing twelve-month dividend of HKD 0.03 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 1846.HK go public?
EuroEyes International Eye Clinic Limited (1846.HK) completed its initial public offering in 2019.